David Buck, MD
Radiation Oncology · Roanoke, VANPI 1952377194
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Bayer at 52.5% of the total. Reporting peaked in 2019 at $6,807 and has fallen 72.7% since, to $1,858 in 2025. Among radiation oncology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $413.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$7K
- Progenics Pharmaceuticals, Inc.$2K
- Novartis$2K
- GE HealthCare$2K
- GT Medical Technologies, Inc$95
- Advanced Accelerator Applications$72
- plus $106 from 3 others
Across 21 payments — averaging $138,279 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.9M
- AstraZeneca$19K
- E.r. Squibb & Sons, L.L.C.$19K
What the payments were for
- Consulting fees$6,66352%
- Speaking & faculty fees$1,98015%
- Travel & lodging$2,99723%
- Food & beverage$1,1739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 11 | $6,722 |
| Progenics Pharmaceuticals, Inc. | 2 | $2,077 |
| Novartis | 6 | $1,904 |
| GE HealthCare | 6 | $1,835 |
| GT Medical Technologies, Inc | 1 | $95 |
| Advanced Accelerator Applications | 1 | $72 |
| Tactile Systems Technology Inc | 2 | $49 |
| Johnson & Johnson | 1 | $44 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,812 in reported general payments places this provider in the 95th percentile of 121 radiation oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate ErTolterodine Tartrate | 11 | $1,767 |
| Lidocaine Hcl ViscousLidocaine Hcl | 80 | $1,715 |
| Mometasone Furoate | 79 | $1,375 |
| Tamsulosin Hcl | 94 | $775 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $399 |
| Dexamethasone | 11 | $349 |
| Oxycodone Hcl | 12 | $107 |
| Diazepam | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Roanoke
- Bret AdamsRoanoke$540
- Daniel KimFairfax$406K
- Samir KananiFairfax$90K
- David PenberthyCharlottesville$67K
- Gopal BajajFairfax$23K
- Ashish ChawlaFairfax$14K
- Kara RomanoCharlottesville$11K
- Gregory SibleyFairfax$10K
- Anthony CrimaldiCulpeper$10K
- Kevin ChoeFairfax$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.